Urine HE4 levels were significantly higher in women with ovarian cancer [12.0 nmol/L (IQR: 10.3–23.1)] compared to those without [6.7 nmol/L (IQR: 3.4–13.6), p = 0.006]. Here, WFDC2 is linked to ovarian carcinoma.